TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35569466

Group type: COMPARATOR
Intervention: PBRT alone (64.8–70.2 Gy at 1.8 Gy per fraction daily)
Number of subjects: 1716

Group type: EXPERIMENTAL
Intervention: PBRT plus short-term ADT
Number of subjects: 1716

Group type: EXPERIMENTAL
Intervention: PLNRT (45 Gy at 1.8 Gy per fraction, followed by a volume reduction for remaining 19.8–25.2 Gy) plus PBRT plus short-term ADT
Number of subjects: 1716

Group type: EXPERIMENTAL
Intervention: Group 3 (PLNRT plus PBRT plus short-term ADT)
Number of subjects: 1716

Group type: EXPERIMENTAL
Intervention: Group 2 (PBRT plus short-term ADT)
Number of subjects: 1716

Group type: COMPARATOR
Intervention: Group 1 (PBRT alone)
Number of subjects: 1716
Study: 34173988

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM.G)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (C.G)
Number of subjects: 70
Study: 32087775

Group type: EXPERIMENTAL
Intervention: Norovirus
Number of subjects: 2298

Group type: EXPERIMENTAL
Intervention: Rotavirus
Number of subjects: 2298
Study: 36240838

Group type: EXPERIMENTAL
Intervention: Evening dosing of antihypertensive medication
Number of subjects: 21104

Group type: COMPARATOR
Intervention: Morning dosing of antihypertensive medication
Number of subjects: 21104
Study: 34078632

Group type: EXPERIMENTAL
Intervention: Electronic version of the Integrated Palliative care Outcome Scale (eIPOS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: eIPOS
Number of subjects: 0

Group type: COMPARATOR
Intervention: IPOS
Number of subjects: 0
Study: 35701067

Group type: COMPARATOR
Intervention: Placebo (two times per day)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 20 mg tadalafil (one time per day) and placebo (one time per day)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 20 mg tadalafil (two times per day)
Number of subjects: 180
Study: 32077402

Group type: EXPERIMENTAL
Intervention: Very Long Roux Limb Roux-en-Y Gastric Bypass (VLRL-RYGB)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Roux-en-Y Gastric Bypass (RYGB)
Number of subjects: 444
Study: 34636057

Group type: EXPERIMENTAL
Intervention: Topical glycopyrronium tosylate 3.75%
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Topical glycopyrronium tosylate 2.5%
Number of subjects: 497

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 497
Study: 32079480

Group type: EXPERIMENTAL
Intervention: Normal ETT results
Number of subjects: 5214

Group type: EXPERIMENTAL
Intervention: Ischemic ETT results
Number of subjects: 5214

Group type: EXPERIMENTAL
Intervention: Nondiagnostic ETT results
Number of subjects: 5214

Group type: EXPERIMENTAL
Intervention: Equivocal ETT results
Number of subjects: 5214
Study: 35034478

Group type: EXPERIMENTAL
Intervention: Sandplay therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Glucocorticoid, immunosuppressant and other drugs (Control Group)
Number of subjects: 40
Study: 33730977

Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg to 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg to 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg to 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg to 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg to 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg to 200 mg
Number of subjects: 0
Study: 36507329

Group type: EXPERIMENTAL
Intervention: H2 inhalation therapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (air inhalation)
Number of subjects: 65
Study: 33256220

Group type: EXPERIMENTAL
Intervention: Matcha Green Tea Powder (3g per day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 61
Study: 36350049

Group type: EXPERIMENTAL
Intervention: Tobacco treatment intervention offered during lung cancer screening at multiple clinical timepoints (RP1, RP2, RP3)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Recruitment point 1 (RP1)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Recruitment point 2 (RP2)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Recruitment point 3 (RP3)
Number of subjects: 177
Study: 32719050

Group type: EXPERIMENTAL
Intervention: Online evidence-based medicine (EBM) supplement
Number of subjects: 34
Study: 34428646

Group type: EXPERIMENTAL
Intervention: Hydroxy selenomethionine (OH‐SeMet) supplementation at 0.2, 0.4, 0.6, and 0.8 mg/kg
Number of subjects: 375

Group type: COMPARATOR
Intervention: Control group with 0.0 mg/kg Se
Number of subjects: 375
Study: 32201122

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (steroid)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lactated Ringer solution (placebo)
Number of subjects: 24
Study: 33888595

Group type: EXPERIMENTAL
Intervention: Shared decision-making
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Nudged information
Number of subjects: 1000

Group type: COMPARATOR
Intervention: No involvement
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Non-treatable cancer diagnosis
Number of subjects: 1000
Study: 34835970

Group type: EXPERIMENTAL
Intervention: Zinc deficiency defined as serum Zn concentration <9.9 µmol/L
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Dietary Zn intake
Number of subjects: 278
Study: 616082294

Group type: EXPERIMENTAL
Intervention: New high viscosity formula (OGD, Refresh Optive Gel Drops, Allergan)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Systane Gel Drops (SGD, Alcon)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Genteal Lubricant Gel Drops (GGD, Novartis)
Number of subjects: 93
Study: 36027785

Group type: EXPERIMENTAL
Intervention: Mindfulness therapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Health education
Number of subjects: 75
Study: 32485294

Group type: EXPERIMENTAL
Intervention: LPS (0.8 ng/kg body weight)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: LPS
Number of subjects: 37
Study: 34330043

Group type: EXPERIMENTAL
Intervention: 3-lesson unguided online treatment program targeting rumination and worry
Number of subjects: 26
Study: 36109694

Group type: EXPERIMENTAL
Intervention: Link-me intervention (Decision Support Tool for mental health care)
Number of subjects: 1671
Study: 34108036

Group type: EXPERIMENTAL
Intervention: Medication monitor reminders and differentiated care (Wisepill evriMED 1000)
Number of subjects: 2610

Group type: COMPARATOR
Intervention: Standard of care (medication monitors for adherence tracking, TB education, normal clinic follow-up)
Number of subjects: 2610
Study: 32493213

Group type: EXPERIMENTAL
Intervention: LMA-Supreme
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: I-gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tracheal tube
Number of subjects: 100
Study: 34730866

Group type: EXPERIMENTAL
Intervention: Women's Recovery Group (WRG)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Group Drug Counseling (GDC)
Number of subjects: 115
Study: 33252635

Group type: EXPERIMENTAL
Intervention: 0.33-mm core microbiopsy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Erbium-YAG laser treatment
Number of subjects: 15
Study: 32238517

Group type: EXPERIMENTAL
Intervention: Industry funded trials
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Trials over time (1998-2008-2018)
Number of subjects: 96
Study: 35861247

Group type: EXPERIMENTAL
Intervention: Exposure to conflicting health information
Number of subjects: 2716

Group type: COMPARATOR
Intervention: Exposure to health news stories and social media posts without conflicting information
Number of subjects: 2716
Study: 34210941

Group type: EXPERIMENTAL
Intervention: 0.12% Chlorhexidine (CHX)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 32985994

Group type: EXPERIMENTAL
Intervention: SMS intervention (behavior change theory‐informed, automated, semi‐interactive SMS)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (no SMS)
Number of subjects: 110
Study: 34668048

Group type: EXPERIMENTAL
Intervention: Readiness for Discharge (RFD) Scale assessment
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: RFD Scale scoring
Number of subjects: 122
Study: 32611102

Group type: EXPERIMENTAL
Intervention: Additional nonlocal wiring to randomly selected nodes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower coupling strength
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suitable choice of switching times, coupling strengths, and number of nonlocal links
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomly switching nonlocal links
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static nonlocal wirings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Absence of nonlocal wirings
Number of subjects: 0
Study: 35241087

Group type: EXPERIMENTAL
Intervention: SHR3680 (80mg, 160mg, 240mg daily)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: SHR3680 (40mg to 480mg daily)
Number of subjects: 197
Study: 32716589

Group type: EXPERIMENTAL
Intervention: Platform-switched abutment (test)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Platform-matching abutment (control)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Delayed-loaded implants
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Immediately loaded implants
Number of subjects: 32
Study: 35114534

Group type: EXPERIMENTAL
Intervention: Endoluminal radiofrequency ablation and metal stent implantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33960504

Group type: EXPERIMENTAL
Intervention: Oral paclitaxel 615 mg/m2 with encequidar 15 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Intravenous paclitaxel 80 mg/m2
Number of subjects: 42
Study: 32324017

Group type: EXPERIMENTAL
Intervention: Parental emotional suppression (suppressing affective state)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control condition (acting naturally)
Number of subjects: 214
Study: 36048234

Group type: EXPERIMENTAL
Intervention: Arthroscopic capsular release (ACR)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Manipulation under anaesthesia (MUA)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness
Number of subjects: 85
Study: 33789908

Group type: EXPERIMENTAL
Intervention: Baseline NMR analytes and their changes
Number of subjects: 2590

Group type: EXPERIMENTAL
Intervention: Baseline 2-hour glucose
Number of subjects: 2590

Group type: EXPERIMENTAL
Intervention: Sophisticated machine learning algorithms
Number of subjects: 2590

Group type: EXPERIMENTAL
Intervention: Standard lipids and demographic and glycemic traits
Number of subjects: 2590
Study: 34724678

Group type: EXPERIMENTAL
Intervention: Ultrasound-Assisted Spinal Anesthesia (USAS)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Ultrasound-Guided Spinal Anesthesia (USRTG)
Number of subjects: 114
Study: 34465357

Group type: EXPERIMENTAL
Intervention: Comprehensive care by a multidisciplinary care team (MDCT)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 98
Study: 35935255

Group type: EXPERIMENTAL
Intervention: Digital training system
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (lectures without digital technologies)
Number of subjects: 24
Study: 34957952

Group type: EXPERIMENTAL
Intervention: 5 drops of oral synbiotic daily along with phototherapy
Number of subjects: 194
Study: 34787778

Group type: EXPERIMENTAL
Intervention: Afatinib 30 mg with daily TMZ and RT
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Afatinib 40 mg with RT alone
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Regimen M (Afatinib + TMZ + RT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Regimen U (Afatinib + RT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 55
Study: 32970697

Group type: EXPERIMENTAL
Intervention: Daily self-administered vaginal progesterone (VP)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 34595960

Group type: EXPERIMENTAL
Intervention: Psychological inoculation (PI) + health information (experimental)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Health information alone (control)
Number of subjects: 0
Study: 33866656

Group type: EXPERIMENTAL
Intervention: Any treatment received
Number of subjects: 5117

Group type: EXPERIMENTAL
Intervention: Care from qualified providers (doctor, nurse, midwife, trained community health worker, pharmacist) within 24 hours
Number of subjects: 5117

Group type: COMPARATOR
Intervention: Distance to primary health facility
Number of subjects: 5117

Group type: EXPERIMENTAL
Intervention: Symptoms indicative of pneumonia and malaria
Number of subjects: 5117

Group type: COMPARATOR
Intervention: Socio-demographic factors (household wealth, maternal education)
Number of subjects: 5117
Study: 35249535

Group type: EXPERIMENTAL
Intervention: Different cover letter content and incentives ($20 or $40)
Number of subjects: 960
Study: 33636650

Group type: EXPERIMENTAL
Intervention: Self-healing intervention (14 sessions of 90-min each)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 37380728

Group type: EXPERIMENTAL
Intervention: Dapagliflozin plus basal‐bolus insulin (DAPA group)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Basal‐bolus insulin alone (INSULIN group)
Number of subjects: 250
Study: 34197281

Group type: EXPERIMENTAL
Intervention: V-01 vaccine (10, 25, and 50 µg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: V-01 vaccine (10 µg) subgroup and elderly participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32369298

Group type: EXPERIMENTAL
Intervention: Topical spray of papaverine on harvested LIMA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Perivascular injection of papaverine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of both methods
Number of subjects: 40
Study: 34676918

Group type: EXPERIMENTAL
Intervention: Ionomeric sealant (IS) (Clinpro XT Varnish)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Calcium-phosphate/fluoride varnish (Ca/PO4‐ /F‐ varnish) (Clinpro White Varnish)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Ionomeric sealant (IS)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Calcium-phosphate/fluoride varnish (Ca/PO4‐ /F‐ varnish)
Number of subjects: 121
Study: 32300897

Group type: EXPERIMENTAL
Intervention: Proprioceptive exercise group (PEG)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 28
Study: 36084898

Group type: EXPERIMENTAL
Intervention: Community health worker (CHW)‐delivered intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual cancer care
Number of subjects: 110
Study: 32179010

Group type: EXPERIMENTAL
Intervention: Stimulated Cycle (STC)
Number of subjects: 119
Study: 36360629

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular training without WB-EMS
Number of subjects: 20
Study: 32158738

Group type: EXPERIMENTAL
Intervention: Behavioral treatment with biopsychosocial perceived etiology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment with biopsychosocial perceived etiology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral treatment with biomedical perceived etiology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment with biomedical perceived etiology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment information wording matching perceived etiology
Number of subjects: 0
Study: 36216984

Group type: EXPERIMENTAL
Intervention: Parent–Child Interaction Therapy‐Emotion Development (PCIT‐ED)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 229
Study: 34601450

Group type: EXPERIMENTAL
Intervention: Guided, eight-week mindfulness program delivered online
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 0
Study: 32711568

Group type: EXPERIMENTAL
Intervention: Clofazimine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33827631

Group type: EXPERIMENTAL
Intervention: Hearing aids intervention
Number of subjects: 464
Study: 35575293

Group type: EXPERIMENTAL
Intervention: Fasudil
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 25
Study: 32888121

Group type: EXPERIMENTAL
Intervention: Rhythm control with antiarrhythmic drugs (AADs)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 210
Study: 32785213

Group type: EXPERIMENTAL
Intervention: 10 µg BNT162b1
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 30 µg BNT162b1
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 100 µg BNT162b1
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 34530210

Group type: EXPERIMENTAL
Intervention: Reactive recruitment strategies (word-of-mouth, flyers)
Number of subjects: 821

Group type: COMPARATOR
Intervention: Proactive recruitment strategies (direct invitations)
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Word-of-mouth
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Flyer distribution (paid strategy)
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Newspaper ads (paid strategy)
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Online advertisements (paid strategy)
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Radio and television ads (paid strategy)
Number of subjects: 821
Study: 34002557

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with lower-limb intelligent feedback training
Number of subjects: 154

Group type: COMPARATOR
Intervention: Lower-limb intelligent feedback training alone
Number of subjects: 154
Study: 32815416

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose anticoagulation with low-molecular-weight heparin or unfractionated heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 36125566

Group type: EXPERIMENTAL
Intervention: Trabecular bone score (TBS) Hip at total hip
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Trabecular bone score (TBS) Hip at femoral neck
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Trabecular bone score (TBS) Hip at greater trochanter
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Trabecular bone score (TBS) at lumbar spine
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Bone turnover markers (BTMs)
Number of subjects: 132
Study: 35923359

Group type: EXPERIMENTAL
Intervention: Short-term oxygen therapy (STOT)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Short-term oxygen therapy (STOT) for more than one month or repeated prescriptions
Number of subjects: 243
Study: 32024447

Group type: EXPERIMENTAL
Intervention: Internet self-help blended with face-to-face therapy
Number of subjects: 11
Study: 35442766

Group type: EXPERIMENTAL
Intervention: Tislelizumab (200 mg every 3 weeks)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Chemotherapy (investigator's choice of paclitaxel, docetaxel, or irinotecan)
Number of subjects: 512
Study: 33825892

Group type: EXPERIMENTAL
Intervention: Vismodegib + Temozolomide (TMZ) (arm A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Temozolomide (TMZ) (arm B)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vismodegib (arm C)
Number of subjects: 24
Study: 32338468

Group type: EXPERIMENTAL
Intervention: Gain-frame SMS
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Loss-frame SMS
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 211
Study: 36348192

Group type: EXPERIMENTAL
Intervention: PWLHIV
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Relationship factors (unmarried, non-cohabitating, shorter, polygamous relationships, HIV non-disclosure, verbal abuse)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: In-depth interviews with 45 women and 45 men
Number of subjects: 500
Study: 33415790

Group type: EXPERIMENTAL
Intervention: Mindfulness microintervention
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Cognitive dissonance microintervention
Number of subjects: 202

Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 202
Study: 32534502

Group type: EXPERIMENTAL
Intervention: GA‐VIBE MRI sequence
Number of subjects: 11

Group type: COMPARATOR
Intervention: CT scans
Number of subjects: 11
Study: 33840341

Group type: EXPERIMENTAL
Intervention: Manual removal of the placenta with intrauterine cleaning (n = 110)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Manual removal of the placenta without intrauterine cleaning (n = 106)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Spontaneous placental delivery with intrauterine cleaning (n = 108)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Spontaneous placental delivery without intrauterine cleaning (n = 112)
Number of subjects: 436
Study: 33471196

Group type: EXPERIMENTAL
Intervention: Transgenic cowpea plants expressing Cry2Aa protein
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (non-transgenic cowpea plants)
Number of subjects: 11
Study: 35501278

Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32045103

Group type: EXPERIMENTAL
Intervention: PRGF‐gel treatment
Number of subjects: 20
Study: 36396600

Group type: EXPERIMENTAL
Intervention: Progressive moderate-vigorous elastic resistance training (2 days/week for 8 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual daily activities (control group)
Number of subjects: 20
Study: 32700151

Group type: EXPERIMENTAL
Intervention: Haptic feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: No haptic feedback
Number of subjects: 0
Study: 32108890

Group type: EXPERIMENTAL
Intervention: Genetically determined Lp(a) levels
Number of subjects: 139362

Group type: EXPERIMENTAL
Intervention: LPA single-nucleotide polymorphisms
Number of subjects: 139362

Group type: EXPERIMENTAL
Intervention: Lp(a) levels equal to or above the 95th percentile
Number of subjects: 139362
Study: 35293287

Group type: EXPERIMENTAL
Intervention: Intravenous bolus brivaracetam 100 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous infusion brivaracetam 100 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral reference tablet brivaracetam 100 mg
Number of subjects: 24